LOOKING FOR OPTIMAL STANDARDS, CRITERIA AND KPIS OF PATIENT CENTRICITY ACROSS THE BIOPHARMA INDUSTRY: AN OVERVIEW OF EXISTING FRAMEWORKS AND CONCEPTUAL MODELS (PART 2)
DOI:
https://doi.org/10.24144/2077-6594.3.2020.208607Abstract
This work reflects the part 2 of our taskforce aimed to comprehensively analyse the selected 12 patient centricity frameworks/conceptual models and related key elements with the focus of their implementation potential and possible operational adoption by the biopharmaceutical industry.
Methods. The implementation potential of the key elements as unified standards, criteria or KPIs in the selected frameworks/conceptual models and their possible adoption across the biopharmaceutical industry were evaluated and discussed using modified Implementation Outcomes Criteria (IOCs), comprehensiveness, appropriateness, feasibility, fidelity, measurability, implementation resources, sustainability and scalability.
Results. Analysis against the modified IOCs showed that the PatientView, KINAPSE and PFMD frameworks have the highest implementation potential across the biopharmaceutical industry.
Conclusions. None can be taken as prototype as originally developed. There is a common need for cross-functional and cross-industry discussions, further piloting, validation and acceptance of the more adoptable key elements as standards and KPIs. These must be co-developed in close collaboration with patient experts, then integrated into corporate strategy and ways of working as workstreams on patient centricity/patient affairs standards.
References
Being Patient-Centric: An evidence-based self-evaluation toolkit for pharma… as recommended by patient groups. PatientView; November 2017.
CTTI Clinical Trial Transformation Initiative. CTTI recommendations: effective engagement with patient groups around clinical trials, October 2015. Access mode: https://www.ctti-clinicaltrials.org/files/pgctrecs.pdf.
Deane K, Delbecque L, Gorbenko O, et al. Co-creation of patient engagement quality guidance for medicines development: an international multi-stakeholder initiative. BMJ Innovation 2019; 0:1–13.
FasteCures Value Framework: Integrating the Patient Perspective into the Development of Value Frameworks, March 2016. Access mode: http://www.fastercures.org/reports/view/56.
Managing Performance in Patient Centricity. Making the link between value for patients and value for the pharmaceutical industry. A Kinapse white paper; 2015: https://info.kinapse.com/patient-centricity.html.
National Health Council (NHC) Framework Dialogue / Advancing Meaningful Patient Engagement in Research, Development, and Review of Drugs, September 22, 2015. Access mode: http://www.nationalhealthcouncil.org/sites/default/ files/PatientEngagement-WhitePaper.pdf.
National Standards for Public Involvement in Research. Multi-stakeholder group: INVOLVE, National Institute for Health Research, 2017; Access mode: https://sites.google.com/nihr.ac.uk/pi-standards/home.
Patient Centricity Frameworks. A practitioner’s guide; Eyeforpharma, December 2017.
PCORI Funded Projects: Sample Engagement Plans From Methods Portfolio, August 6, 2014. Access mode: http://www.pcori.org/sites/default/files/PCORI-Sample-Methods-Engagement-Plans.pdf.
PCORI Patient Engagement Rubric Engagement Rubric for Applicants, Feb 4, 2014 (updated June 6, 2016). Access mode: http://www.pcori.org/sites/default/files/Engagement-Rubric.pdf.
People and Communities Board. Six principles for engaging people and communities: Definitions, evaluation and measurement. Published by the People and Communities Board, with support from National Voices, UK; June 2016; Access mode: https://www.nationalvoices.org.uk/sites/default/files/public/publications/six_principles_-_definitions_evaluation_and_ measurement_-_web_high_res_0_1.pdf.
Perfetto et al. Framework: When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption, in Journal of Comparative Effectiveness Research, July 2013, Vol. 2, No. 4, Pages 383-391. Access mode: http://www.futuremedicine.com/doi/pdfplus/10.2217/cer.13.39.
Proctor E, Silmere H, Raghavan R, et al. Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda. Adm Policy Ment Health (2011) 38:65–76.
Taylor J. Oral presentation at the Patient Summit Europe 2018, session “Discover the organisational blueprint for scaling patient centricity” / Being Patient-Centric: A National Voices Perspective; 16 October, London; https://s3.amazonaws.com/efpharma/patient2018/slides/D2-26+(b)+Jeremy.pdf.
University of Maryland M-CERSI Framework. Assessing meaningful patient engagement in drug development: a definition, framework, and rubric, March 2015. Access mode: http://www.pharmacy.umaryland.edu/media/SOP/ wwwpharmacyumarylandedu/centers/cersievents/pfdd/mcersi-pfdd-framework-rubric.pdf.
